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Abstract The domain structure of hemagglutinin-neuramini-
dase from Sendai virus (cHN) was investigated by studying the
thermal stability in the 20^100‡C range. Differential scanning
calorimetry evidences two conformational transitions. The first
transition is apparently a reversible two-state process, with Tm
48.3‡C, and is shifted to 50.1‡C in the presence of the substrate
analogue 2,3-dehydro-2-deoxy-N-acetyl neuraminic acid, mean-
ing that the substrate binding domain is involved in the transition.
The second transition, with apparent Tm 53.2‡C, is accompanied
by irreversible loss of enzymatic activity of the protein, and the
presence of the substrate analogue does not affect the Tm. The
data indicate that cHN is composed of two independent folding
domains, and that only one domain is involved in the binding of
the substrate. Our results suggest that the paramyxovirus
neuraminidases have the folding properties of a two-domain
protein. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Paramyxoviridae are a family of enveloped viruses which
cause a large number of pathologies in both humans and
animals. The envelope of paramyxovirus contains two glyco-
proteins, the fusion protein (F) and the hemagglutinin-neur-
aminidase (HN). The three-dimensional structure of a para-
myxovirus neuraminidase has recently been reported [1],
showing that the HN has the same folding topology as in£u-
enza neuraminidase. The experimentally determined structure
con¢rms the prediction obtained by comparing conserved res-
idues of viral and bacterial neuraminidases, whose three-di-
mensional structure is known, with paramyxovirus HN [2,3].
However, there are some functional di¡erences between the
neuraminidases of paramyxoviruses and the other neuramini-
dases [4,5] because HN is involved in the fusion process, being
necessary for the activity of the F protein [6^11].
The presence of multiple functions is a unique feature of
paramyxovirus HN, with no counterpart on in£uenza virus or
bacterial neuraminidases. Thus it is interesting to know how
the three-dimensional structure can account for all the activ-
ities of HN.
In the presence of detergents that disrupt the viral envelope,
HN is cleaved selectively by trypsin at arginine 131 [12], and
the C-terminal part is released as a soluble protein (cHN).
cHN is a disul¢de-linked homodimer, which fully retains the
enzymatic activity of the intact protein. In the present report
we have investigated the thermal stability of the cHN and we
show that the structure is formed by at least two di¡erent
folding domains.
2. Materials and methods
Unless otherwise stated, all experiments were performed in 10 mM
phosphate bu¡er, pH 7.4, containing 0.15 M NaCl (PBS).
Sendai virus was grown in the allantoic cavity of 10-day embryo-
nated eggs, and puri¢ed as previously described [13]. The water-solu-
ble cHN was prepared with a new procedure. Brie£y, HN was solu-
bilized as previously described [14], and was treated with trypsin (5%
by weight of the viral proteins) for 20 min at room temperature. The
solution was passed through a column of Amberlite XA2 (9U1.7 cm)
to remove the detergent, and the £ow-through was poured into a
phosphocellulose column (9U1.7 cm) equilibrated in 10 mM MES,
150 mM NaCl, pH 6.0. The unabsorbed material, containing cHN,
was concentrated by centrifugation on Centricon CF25 (Amicon), and
appeared as a single band on SDS^PAGE. Despite the apparent pu-
rity, cHN was still contaminated by a very small amount of an un-
known proteolytic activity, which was removed by gel ¢ltration on a
column (1.2U100 cm) of Sephacryl S-200 (Pharmacia), equilibrated in
PBS. The cHN concentration was determined by the absorbance at
280 nm, with E1% = 10.83 [15].
Enzymatic activity was assayed at 37‡C as previously described [16].
Proteolytic activity was assayed using azocasein (Sigma) as substrate.
Fluorescence measurements were performed in a Perkin-Elmer spec-
tro£uorimeter with thermostated cell holder, and the temperature of
the sample was read in the cuvette with a PT100 thermoresistance.
The heating rate was maintained at 1.0 þ 0.2‡C/min. The fraction of
denatured protein at temperature T, fd(T), was calculated from:
fdT  FT3FminT
F maxT3FT
where F(T) is the £uorescence at temperature T, Fmin(T) and Fmax(T)
are the extrapolated values from the linear regression of the ln (£uo-
rescence) versus 1/T before and after the transition respectively. The
£uorescence emission was read at 330 and 350 nm with excitation at
280 nm.
Di¡erential scanning calorimetry (DSC) measurements were per-
formed with a Microcal VP microcalorimeter, and the data were pro-
cessed with the software provided by the manufacturer. Baseline was
constructed by ¢tting a third order polynomial to the data points
before (26^36‡C) and after (65^80‡C) transition. Curve ¢tting was
used to estimate the Tm and the enthalpy change associated with
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 2 3 6 2 - 6
*Corresponding author. Fax: (39)-53-2202723.
E-mail: blt@unife.it
FEBS 24794 17-4-01
FEBS 24794FEBS Letters 495 (2001) 48^51
the transition of the component peaks when the thermogram was the
summation of overlapping peaks. The deconvolution was based on
the assumption that the thermograms can be described in terms of a
linear combination of more than one independent transition, each
approximating a two-state transition.
Selective proteolysis was performed using the partially puri¢ed cHN
(before the ¢nal gel ¢ltration step). The protein was extensively dia-
lyzed against PBS, and, after incubation at the desired temperature,
peptides were separated by SDS^PAGE and blotted onto PVDF
membranes (Millipore). Bands, stained with Coomassie blue, were
cut and subjected to amino-terminal sequencing.
3. Results
3.1. Calorimetric studies of cHN denaturation
Thermal denaturation of cHN, studied by DSC, shows a
two-component endothermic transition. The experimental
curve and the theoretical curves that best ¢t the experimental
data are reported in Fig. 1 (lower trace), and show the pres-
ence of partially overlapping peaks, the ¢rst with Tm 48.3‡C,
and the second with Tm 53.2‡C. In the presence of the sub-
strate analogue, 2,3-dehydro-2-deoxy-N-acetyl neuraminic
acid (DNANA), the best ¢t of the heat capacity vs. temper-
ature plot was again obtained by two overlapping peaks. The
temperature transition of the ¢rst peak, previously centered at
48.3‡C, increased to 50.5‡C while the temperature of the sec-
ond peak remained constant (53.1‡C) (Fig. 1, upper trace).
These data suggest that cHN is composed of two di¡erent
folding domains, but only one involved in the binding of the
substrate. The overall transitions observed by DSC appear to
be irreversible, since no signi¢cant transitions were detected
during cooling or a second heating cycle.
3.2. Fluorescence study of cHN denaturation
Temperature-induced unfolding of cHN was investigated
determining the solvent accessibility of the tryptophan resi-
dues, by measuring the ratio of the £uorescence emission at
330 and 350 nm in the 25^75‡C range. When the temperature
was raised to 75‡C, the 330/350 ratio slowly decreased from
1.20 to 1.15, without any evidence of a cooperative change
(Fig. 2). This means that the solvent exposure of the trypto-
phan residues does not change in the temperature range
studied, and therefore that cHN does not unfold at temper-
atures where DSC evidences the thermal transitions.
The denaturation of cHN can also be observed by measur-
ing the intensity of the intrinsic £uorescence of the protein.
When the £uorescence emission intensity was measured (Fig.
2), a sharp increase was observed between 35‡C and 55‡C, and
the presence of DNANA shifted the apparent Tm from 49‡C
to 51‡C. This means that, in the 35^55‡C range, there is a
thermal transition sensitive to the presence of the substrate
analogue.
The transition could not be detected during a second heat-
ing cycle; however, when the ¢rst heating cycle was stopped at
temperatures below 50‡C, a second heating cycle still detected
the thermal transition. The transitions observed during the
¢rst and the second heating cycles are nearly identical if the
temperature of the ¢rst cycle did not exceed 47‡C. These data
suggest that while complete unfolding occurs at temperatures
higher than 75‡C, cHN undergoes a reversible conformational
transition(s) at about 49‡C, followed by an irreversible inacti-
vation. The changes in the £uorescence intensity are clearly
correlated with the ¢rst transition observed by DSC, since in
both cases the presence of the substrate analogue shifts the Tm
to higher temperatures. In addition the Tm obtained by £uo-
rescence measurements is in quite good agreement with that
measured by DSC both in the absence and in the presence of
DNANA (Table 1).
3.3. Selective proteolysis of cHN
Attempts to investigate the cHN denaturation by selective
proteolysis with commercial proteases (trypsin, Staphylococ-
Fig. 1. Thermal denaturation of cHN. The excess heat capacity was
recorded at 60‡C/h in PBS. Baseline-subtracted DSC recording of
cHN (0.4 mg/ml) (lower trace) and cHN in the presence of 0.4 mM
DNANA (upper trace). In both cases the best ¢t of the experimen-
tal data is obtained assuming two non-two-state transitions. Solid
line: experimental data; dashed line, ¢tted data.
Fig. 2. Temperature dependence of the intrinsic £uorescence of
cHN. Fluorescence emission intensity of cHN (0.05 mg/ml) at 330
and 350 nm was recorded in PBS at a heating rate of 1‡C/min.
Empty circles (right ordinate): ratio of emission at 330/350; ¢lled
diamonds (left ordinate): £uorescence intensity at 330 nm in the ab-
sence of DNANA; empty triangles: £uorescence intensity at 330 nm
in the presence of DNANA.
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cus aureus V8 protease, pronase) were unsuccessful. A host-
derived protease [17], which is separated from cHN in the last
step of puri¢cation, selectively degrades cHN as the temper-
ature rises to 45^50‡C (Fig. 3). At 28‡C, the proteolytic ac-
tivity measured on azocasein was one third of the activity
measured at 48‡C. However, incubation of cHN at 28‡C for
up to 60 min did not cause appreciable digestion, while at
48‡C a 5 min digestion showed the appearance of degradation
products. This means that the protease is e¡ective on cHN
only after the thermal transition observed both by DSC and
by £uorescence measurements. The presence of the substrate
analogue DNANA protects against the proteolytic digestion,
suggesting that the protease acts on the cHN domain involved
in the binding of the substrate. When the digestion was car-
ried out at 55‡C, a temperature higher than the second tran-
sition detected by DSC, cHN was completely degraded and
DNANA did not exert any protective e¡ect.
The digestion of cHN yielded two main peptides, with ap-
parent MWs, determined by SDS^PAGE, of 30 and 27 kDa.
Amino-terminal sequencing of the two peptides gave the se-
quence QELT (the N-terminal sequence of cHN) for the 27
kDa peptide, and the sequence ITWL (sequence 371^374 of
HN) for the 30 kDa peptide, meaning a protease cut at the
lysine 370.
4. Discussion
DSC data show that two di¡erent domains, undergoing a
thermal transition at di¡erent temperatures, are present in
cHN. The thermal transition of the ¢rst domain, centered at
a lower temperature, is accompanied by an increase of the
intrinsic £uorescence of the protein. This domain is involved
in the binding of the substrate, since the presence of the sub-
strate analogue DNANA shifts its Tm at higher temperatures.
The thermal transition of the second domain is irreversible,
and this domain does not appear to be involved in the binding
of the substrate, since DNANA does not modify the Tm of the
transition.
The possibility that the DSC is detecting two sequential
structural changes on a single domain must be ruled out, since
the two transitions are very close, but only the one occurring
at the lower temperature is a¡ected by the presence of the
substrate analogue DNANA.
The denaturation analysis shows that cHN is composed of
di¡erent folding units. This is not surprising, because a 51
kDa protein can easily account for two or even three folding
units. Two folding units are likely present also in the HN of
other paramyxoviruses [18]. However, only one domain is in-
volved in the binding of the substrate. This raises the question
of the compatibility with the three-dimensional structure of
paramyxovirus neuraminidases [1^3,19]. The known bacterial
and viral neuraminidases all have the same structure [20^23],
the so-called L6-propeller. This structure is composed of six
four-stranded L-sheets, arranged like the blades of a propeller,
with the C- and N-terminal parts forming the sixth L-sheet.
Since the amino acids involved in the binding of the substrate,
or in the catalytic activity, are located on ¢ve of the six
L-sheets of the propeller, the substrate binding is expected
to a¡ect the stability of the whole domain. The known L-pro-
peller structures are composed of about 380 amino acids,
while cHN is composed of 444 amino acids, meaning that if
the L-propeller structure is present, the second folding unit
should comprise about 100 amino acids. The alignment of
the sequence of Sendai virus with that of Newcastle disease
virus shows that the L-propeller structure should span from
the N-terminal to the C-terminal part of the cHN, which
comprises only the residues 132^575 of HN [1,19]. Thus
the structure does not allow a second domain at the N- or
C-terminal end of the protein. A second, substrate-independ-
ent, folding unit should be inserted within a loop of the L-pro-
peller, in a way similar to that suggested for the measles hem-
agglutinin [3] or for the Vibrio neuraminidase [22]. However,
sequence alignment does not allow a loop within the L-pro-
peller large enough to account for a second folding domain.
The largest domain outside the L-propeller structure is a 40
amino acid K-helical domain between amino acids 340 and
380; however, limited proteolysis shows that this domain,
containing Lys 370, can be unambiguously assigned to the
substrate binding domain, because the presence of the sub-
strate protects against proteolytic digestion. The limited pro-
teolysis at Lys 370 shows that the only site allowed for a
second, substrate-independent, domain is at or near the sub-
strate binding domain. The second domain could be the sub-
Table 1
Thermodynamic parameters of the denaturation process of cHN
Tm (‡C)
Peak 1 Peak 2
Calorimetric Fluorescence Calorimetric Fluorescence
cHN 48.3 49.8 53.2 nd
cHN+DNANA 50.5 51.1 53.1 nd
nd: not detected.
Fig. 3. Limited proteolysis of cHN. MW standards (lane 1) are: bo-
vine serum albumin (67 kDa), ovalbumin (45 kDa), lactate dehydro-
genase (35 kDa), soybean trypsin inhibitor (20.4 kDa). Partially pu-
ri¢ed cHN was incubated: for 30 min at 28‡C in the presence (lane
3) and in the absence of DNANA (lane 4); for 5 min at 48‡C in
the presence (lane 6) and in the absence (lane 7) of DNANA; for
5 min at 55‡C in the presence (lane 9) and in the absence of DNA-
NA (lane 10).
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unit interface domain; however, the X-ray structure of New-
castle disease virus shows large changes of the subunit inter-
face upon binding of the substrate analogue. The assignment
of a transition to changes at the subunit interface cannot be
experimentally tested, because the subunits are covalently
linked by a disul¢de bridge.
While the denaturation experiments are unexpected on the
basis of the three-dimensional structure, the evidence of two
di¡erent folding domains accounts well for the di¡erent bio-
logical activities of cHN. We have already shown that cHN is
composed of two functional domains, a catalytic domain and
an inhibitory domain [24], and the presence on Sendai virus of
di¡erent functional domains has been also suggested by Port-
ner et al. [6,25]. The evidence here reported of two independ-
ent folding domains gives a structural basis for the di¡erent
functions.
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